|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Share-based compensation expense | |||||
| Depreciation and amortization of property and equipment | |||||
| Depreciation and amortization | |||||
| Net amortization of discounts on investments | |||||
| Amortization of deferred commission costs | |||||
| Unrealized foreign currency (gain) loss | |||||
| Loss on disposal of assets | |||||
| Amortization of intangible assets | |||||
| Non-cash operating lease costs | |||||
| Impairment of long-lived assets | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Other accrued liabilities | |||||
| Accrued compensation and related benefits | |||||
| Deferred commissions | |||||
| Deferred revenue | |||||
| Other long-term liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Proceeds from early termination of short-term investments | |||||
| Purchases of long-term investments | |||||
| Proceeds from maturity of investments | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from liquidation of a long-term investment | |||||
| Capitalized internal-use software development costs | |||||
| Purchases of intangible assets | |||||
| Payments for business acquisitions, net of cash and restricted cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from follow-on offering of common stock, net of underwriters' discounts and commissions | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Proceeds from contributions to Employee Stock Purchase Plan | |||||
| Payments on principal of finance leases | |||||
| Payments of deferred offering costs | |||||
| Net cash provided by financing activities | |||||
| Effects of changes in foreign currency exchange rates on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures | |||||
| Cash paid for interest | |||||
| Cash paid for income tax | |||||
| Accrued purchases of property and equipment, including internal-use software | |||||
| Deferred offering costs, accrued but not yet paid | |||||
| Fair value of shares issued as consideration for acquisition | |||||
| Share-based compensation capitalized in internal-use software development costs | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Right-of-use assets reductions related to operating leases | |||||
| Purchases of fixed assets under finance leases | |||||
Loading...